​

Envoy Medical Stock (NASDAQ:COCH)

RevenueOwnershipFinancialsChart
Envoy Medical by TradingView

Previous Close

$0.65

52W Range

$0.36 - $1.89

50D Avg

$0.68

200D Avg

$0.75

Market Cap

$13.12M

Avg Vol (3M)

$138.71K

Beta

1.89

Div Yield

-

COCH Company Profile

Envoy Medical, Inc. is a healthcare company dedicated to developing innovative medical technologies that address the full spectrum of hearing loss. Its diverse product portfolio includes conventional hearing aids, Esteem middle ear implants, bone conduction devices, and Acclaim cochlear implants. Established in 1995, the company originally operated as St. Croix Medical, Inc. before officially rebranding to Envoy Medical, Inc. in December 2004. Envoy Medical, Inc. is headquartered in White Bear Lake, Minnesota.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

42

IPO Date

Apr 29, 2021

Website

COCH Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 25
Other Operating Segment$874.00K

Fiscal year ends in Dec 25 | Currency in USD

COCH Financial Summary

Dec 25Dec 24Dec 23
Revenue$241.00K$225.00K$316.00K
Operating Income-$-19.26M$-18.36M
Net Income$-23.76M$-20.80M$-29.92M
EBITDA-$-19.81M$-29.79M
Basic EPS$-1.23$-1.49$-2.54
Diluted EPS$-1.23$-1.49$-2.54

Fiscal year ends in Dec 25 | Currency in USD

Peer Comparison

TickerCompany
HCTIHealthcare Triangle, Inc.
IRIXIRIDEX Corporation
ALURAllurion Technologies Inc.
ATHAAthira Pharma, Inc.
ADTXAditxt, Inc.
CODXCo-Diagnostics, Inc.
VVOSVivos Therapeutics, Inc.
VSEEVSee Health, Inc.
NVNOenVVeno Medical Corporation
ADGMAdagio Medical Holdings, Inc.